C2 Biotechnologies Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by C2 Biotechnologies and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 C2 Biotechnologies employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that C2 Biotechnologies has purchased the following applications: Olark Live Chat for Chatbots and Conversational AI in 2016, Joomla 3.9 for Web Content Management in 2013 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems C2 Biotechnologies is running and its propensity to invest more and deepen its relationship with Olark , Joomla or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing C2 Biotechnologies revenues, which have grown to $1.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for C2 Biotechnologies intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.